Published in Gastroenterology on December 01, 1991
Mechanisms of disease: Inborn errors of bile acid synthesis. Nat Clin Pract Gastroenterol Hepatol (2008) 1.13
Chronic iron overload in rats induces oval cells in the liver. Am J Pathol (1996) 0.93
Bile salt-induced biliary excretion of iron in iron-loaded rats. Gastroenterology (1992) 0.75
Idiopathic neonatal hepatitis presenting as neonatal hepatic siderosis and steatosis. Dig Dis Sci (1998) 0.75
A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem (2000) 8.52
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06
Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med (2001) 3.87
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med (1997) 3.49
Non-invasive assessment of hepatic iron stores by MRI. Lancet (2004) 3.38
Delirium in an intensive care unit: a study of risk factors. Intensive Care Med (2001) 3.23
Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology (2000) 3.16
Insulin resistance-associated hepatic iron overload. Gastroenterology (1999) 3.07
Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology (2001) 2.75
A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamines et Minéraux AntioXydants. Control Clin Trials (1998) 2.68
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology (1999) 2.63
Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry (2005) 2.54
A new syndrome of liver iron overload with normal transferrin saturation. Lancet (1997) 2.36
Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. Mol Endocrinol (1991) 2.07
Carcinoma of the hepatic hilus. Surgical management and the case for resection. Ann Surg (1979) 2.05
Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology (1992) 2.00
The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology (2001) 1.99
Mechanism of phenobarbital-induced hypercholeresis in the rat. Am J Physiol (1970) 1.99
Second generation (RIBA) test in diagnosis of chronic hepatitis C. Lancet (1991) 1.84
EASL International Consensus Conference on Haemochromatosis. J Hepatol (2000) 1.76
A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol (1997) 1.72
Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology (1998) 1.69
Association of sleep-wake habits in older people with changes in output of circadian pacemaker. Lancet (1992) 1.63
Cell types involved in collagen and fibronectin production in normal and fibrotic human liver. Hepatology (1986) 1.52
The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat. J Biol Chem (2001) 1.52
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology (2001) 1.51
Effect of inhibitors of sodium transport on bile formation in the rabbit. Am J Physiol (1970) 1.49
Thoracic splenosis after blunt trauma: frequency and imaging findings. AJR Am J Roentgenol (1993) 1.48
Characterization of non-transferrin-bound iron clearance by rat liver. J Biol Chem (1986) 1.46
Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology (1981) 1.45
Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology (1987) 1.45
Vitamin B intake and status in healthy Havanan men, 2 years after the Cuban neuropathy epidemic. Br J Nutr (2001) 1.45
Prostate cancer susceptibility genes: lessons learned and challenges posed. Endocr Relat Cancer (2003) 1.44
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C. Ann Intern Med (1997) 1.44
Serum concentrations of beta-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur J Clin Nutr (2005) 1.44
Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem Pharmacol (1993) 1.43
Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology (1996) 1.41
Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics (1996) 1.41
Hypoprothrombinemia and cefotaxime. Am J Gastroenterol (1990) 1.38
Fatal congestive heart failure with deferiprone. Gastroenterol Clin Biol (2008) 1.38
A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. Amyotroph Lateral Scler Other Motor Neuron Disord (2001) 1.36
Serum ferritin as a possible marker of the hemochromatosis allele. N Engl J Med (1979) 1.35
Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology (1999) 1.35
Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states. J Clin Invest (1985) 1.32
Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol (1990) 1.31
Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med (1998) 1.28
Circadian and homeostatic sleep regulation in morningness-eveningness. J Sleep Res (2006) 1.28
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology (1996) 1.26
Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut (1997) 1.26
A point mutation in the bulge of the iron-responsive element of the L ferritin gene in two families with the hereditary hyperferritinemia-cataract syndrome. Blood (1998) 1.25
Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology (1993) 1.25
Factors influencing blood concentration of retinol, alpha-tocopherol, vitamin C, and beta-carotene in the French participants of the SU.VI.MAX trial. Eur J Clin Nutr (2006) 1.25
The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology (1997) 1.25
Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology (1998) 1.24
Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology (1994) 1.23
Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci U S A (2000) 1.22
Release of calcium from the endoplasmic reticulum by bile acids in rat liver cells. J Biol Chem (1988) 1.21
Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1992) 1.21
Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen. Behav Brain Res (2005) 1.20
Duodenal mRNA expression of iron related genes in response to iron loading and iron deficiency in four strains of mice. Gut (2002) 1.19
Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma? Hepatology (1984) 1.19
Role of cellular zinc in programmed cell death: temporal relationship between zinc depletion, activation of caspases, and cleavage of Sp family transcription factors. Biochem Pharmacol (2001) 1.18
Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France). J Am Coll Nutr (1997) 1.18
High yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver. Cell Biol Int Rep (1982) 1.18
Seasonal and diurnal patterns of human illumination under natural conditions. Chronobiol Int (1998) 1.17
Factor V Leiden related Budd-Chiari syndrome. Gut (2001) 1.17
Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J Hepatol (1997) 1.16
Characteristics of bile acid-mediated Ca2+ release from permeabilized liver cells and liver microsomes. J Biol Chem (1989) 1.16
Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol (2000) 1.15
Mechanisms and control of secretion of bile water and electrolytes. Gastroenterology (1974) 1.15
Ectopic hepatocellular carcinoma arising in the left chest wall: a long-term follow-up. Eur J Gastroenterol Hepatol (2001) 1.15
Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int (2005) 1.15
Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells. J Biol Chem (1990) 1.15
Hepatocellular uptake of taurocholate in the dog. J Clin Invest (1975) 1.14
Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol (2000) 1.13
The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology (1993) 1.12
Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology (1993) 1.12
Zinc homeostasis-regulating proteins: new drug targets for triggering cell fate. Curr Drug Targets (2003) 1.11
Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem (1999) 1.11
Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol (1998) 1.11
Alpha-fetoprotein in amniotic fluid. Lancet (1973) 1.10
An HLA-All association with the hemochromatosis allele? Clin Genet (1983) 1.10
The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum Genet (2004) 1.09
Determining factors in the iron status of adult women in the SU.VI.MAX study. SUpplementation en VItamines et Minéraux AntioXydants. Eur J Clin Nutr (1998) 1.09
Genetics of hemochromatosis: HLA association and mode of inheritance. Ann N Y Acad Sci (1988) 1.09
Concentration of selected metals in normal and pathological human seminal plasma. J Trace Elem Electrolytes Health Dis (1988) 1.09
Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport. Gastroenterology (1980) 1.08